流動資産 変化する 日付
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Akebia Therapeutics USD 220.78M 8.77M 2026-09
ALKERMES USD 1.58B 57.83M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.36B 598M 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Exelixis USD 1.32B 70.8M 2026-09
Immunic USD 135.09M 22.75M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
MacroGenics USD 295.08M 26.61M 2026-09
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Prothena USD 273.86M 18.15M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09